 |
|
|
|
 |
|
|
| Article 1 to 10 out of 13 concerning ProBioGen AG
|
-
Patent granted for ProBioGen's avian cell line AGE1.CR
(14 Jul 2008)
ProBioGen AG, a biotechnology company in cell engineering and production of biopharmaceuticals, has been granted patent protection for AGE1.CR, a proprietary duck cell line developed for the production of human and animal vaccines and proteins.The ...
-
ProBioGen and Boehringer Ingelheim enter into Strategic Production Alliance
(02 May 2008)
ProBioGen AG announced a strategic production agreement with Boehringer Ingelheim. Under the agreement, ProBioGen will integrate some of Boehringer Ingelheim´s technologies to accommodate a seamless process and technology transfer from pilot and ...
-
ProBioGen Announces Exclusive Licensing Agreement for its Proprietary Avian Cell Line AGE1.CR
(10 Dec 2007)
Significant upfront and milestone payments plus royalties for four indications
ProBioGen AG announced the closing of an exclusive licensing agreement for its avian cell line AGE1.CR. The agreement was signed with an undisclosed US vaccine development company and covers a total of four indications, including different forms of ...
-
Dr Gertraud Unterrainer Joins ProBioGen as Chief Financial Officer
(11 Oct 2007)
ProBioGen AG announced the appointment of Dr Gertraud Unterrainer to Chief Financial Officer. Dr Unterrainer will complement and strengthen ProBioGen's current management team consisting of Michael Schlenk, CEO, and Dr Uwe Marx, CSO.Dr Unterrainer ...
-
ProBioGen reinforces its Business Development Team
(31 Aug 2007)
ProBioGen AG announced that Dr Klaus Stünkel will take over the position of Vice President Business Development Licensing with immediate effect. Mr Stünkel brings with him experience gathered over many years in the areas of Business Development ...
-
ProBioGen and Minapharm Enter into Development and Co-promotion Agreements
(24 Apr 2007)
ProBioGen and Minapharm jointly announced that they have entered into two separate agreements to develop two therapeutic proteins, one exclusively for Minapharm and another second generation biopharmaceutical product for co-promotion. In the first ...
-
Affitech contracts with ProBioGen for producer cell line generation for oncology antibody candidate
(13 Apr 2007)
ProBioGen AG, and Affitech AS, jointly announced that they have entered into an agreement for a biopharmaceutical cell line to be developed by ProBioGen for high-level production of one of the lead candidates in Affitech's oncology therapeutic ...
-
ProBioGen and Evotec Technologies Announce Successful Completion of Collaboration on Automated Cell Selection Technology
(01 Sep 2006)
ProBioGen AG and Evotec Technologies GmbH have announced the successful completion of their collaboration - the joint evaluation of methods and instrumentation for the selection of high producer cells. ProBioGen could show based on it's cell-based ...
-
ProBioGen Signed Agreement on Testing of Neuronal Cell Lines with Serono
(10 Apr 2006)
ProBioGen AG announced that Serono S.A., Switzerland has signed an agreement to evaluate ProBioGen's novel human neuronal cell line for the production of recombinant proteins.Under the terms of the Agreement, Serono will explore the feasibility of ...
-
ProBioGen and Saxonia BioTec to optimise new types of bioreactors for research and diagnostics
(03 Dec 2004)
The internationally renowned specialist for mammalian cell lines ProBioGen AG, has established a long-term collaboration with Saxonia BioTec GmbH. The objective of this collaboration is to optimise a new generation of bioreactors developed by ...
Additional information
ProBioGen AG
Berlin, Germany
Company
|
|
|
|
|
|
Top
